Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1) : Formal Consensus Method for the Development of Guidelines for Standardized Time-to-event Endpoints' Definitions in Cancer Clinical Trials

NCT03676010 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT03676010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03676010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1) : Formal Consensus Method for the Development of Guidelines for Standardized Time-to-event Endpoints' Definitions in Cancer Clinical Trials
Lead sponsor
Institut Bergonié
Phase
Observational
Overall status
Active, not recruiting
Start date
September 30, 2009
Completion date
December 31, 2026
Enrollment
265 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer